International Business News - SNY http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Shares of European pharmaceutical companies mostly traded higher Tuesday afternoon, with the top gainers including GlaxoSmithKline PLC and AstraZeneca PLC. http://www.ibtimes.com/articles/20080708/adrs-in-focus-european-pharma-shares-rise.htm Tue, 08 Jul 2008 14:41:23 EDT Shares of Teva Pharmaceutical Industries Ltd. inched up in premarket trading Tuesday, and a Goldman Sachs analyst recommended the stock despite disappointing trial results for Teva's multiple sclerosis drug Copaxone. http://www.ibtimes.com/articles/20080708/ahead-of-the-bell-teva-shares-edge-up.htm Tue, 08 Jul 2008 07:34:16 EDT Shares of Teva Pharmaceutical Industries Ltd. fell Monday after the company posted disappointing results from a higher-dose trial of multiple sclerosis drug Copaxone. http://www.ibtimes.com/articles/20080707/out-of-the-gate-teva-drops-on-copaxone-results.htm Mon, 07 Jul 2008 10:41:54 EDT Shares of Barr Pharmaceuticals Inc. rose Friday as a Delaware federal court invalidated several patents covering Boehringer Ingelheim Pharmaceuticals Inc.'s Mirapex, opening the door for a generic launch. http://www.ibtimes.com/articles/20080627/barr-shares-rise-on-mirapex-patent-case-victory.htm Fri, 27 Jun 2008 12:38:40 EDT Shares of pharmaceutical companies opened mostly higher Friday as the broader market shifted between gains and losses, as a new high in rise in oil prices was tempered by reports of increases in personal incomes and spending. http://www.ibtimes.com/articles/20080627/opening-glance-pharmaceuticals-mostly-higher.htm Fri, 27 Jun 2008 10:12:57 EDT Shares of pharmaceutical companies opened mostly lower Thursday as the broader market declined on a rise in oil prices and Goldman Sachs' downgrade of the brokerage sector. http://www.ibtimes.com/articles/20080626/opening-glance-pharmaceuticals.htm Thu, 26 Jun 2008 09:53:03 EDT Pharmaceutical stocks may have ended Wednesday's trading session mostly in the green, but stocks are still down substantially year to date, and a JPMorgan analyst cautioned that big pharma is no longer a strong defensive choice in a weak economy. http://www.ibtimes.com/articles/20080625/sector-wrap-big-pharma.htm Wed, 25 Jun 2008 16:47:05 EDT Millions of children and teenagers in poor countries may soon be vaccinated against seven common diseases, health officials said Wednesday. Officials at GAVI, formerly known as the Global Alliance for Vaccines and Immunization, announced they have prioritized vaccines for cervical cancer, cholera, typhoid, meningitis A, rabies, Japanese encephalitis and rubella. The vaccines will go to the world's 73 poorest countries. http://www.ibtimes.com/articles/20080625/groups-to-buy-millions-of-vaccines-for-children.htm Wed, 25 Jun 2008 15:23:57 EDT GlaxoSmithKline PLC said Wednesday it won Food and Drug Administration approval for a combination booster vaccine, Kinrix, which protects children ages 4 to 6 against diphtheria, tetanus, pertussis and polio with a single shot. http://www.ibtimes.com/articles/20080625/fda-oks-glaxosmithkline-kids-combination-vaccine.htm Wed, 25 Jun 2008 09:38:17 EDT Eli Lilly shares hit a new 52-week low Tuesday, a day after the company announced the Food and Drug Administration needed three more months to review its blood thinner drug. http://www.ibtimes.com/articles/20080624/fda-delays-decision-on-eli-lilly-blood-clot-drug.htm Tue, 24 Jun 2008 16:50:10 EDT French pharmaceutical maker Sanofi-Aventis spent over $1.2 million in the first quarter lobbying the U.S. government on prescription drug issues, according to a recent disclosure form. http://www.ibtimes.com/articles/20080620/sanofi-aventis-spent-1-2-million-lobbying-in-1q.htm Fri, 20 Jun 2008 09:09:40 EDT Among the stock activity stories for Wednesday, June 18, from AP Financial News: NEW YORK (AP)--Shares of General Motors Corp. and Ford Motor Co. tumbled Wednesday as worries about a slumping economy and rising oil prices boosted fears that automotive sales could drop more this year than previously expected. http://www.ibtimes.com/articles/20080618/movers-roundup-autos-sanofi-aventis.htm Wed, 18 Jun 2008 18:02:25 EDT French drug maker Sanofi-Aventis' planned $2.56 billion takeover bid of Czech generic-drug maker Zentiva could help expand Sanofi's presence in eastern Europe and give it a footing in the generics markets, analysts say. http://www.ibtimes.com/articles/20080618/analysts-sanofis-zentiva-bid-may-signal-strategy.htm Wed, 18 Jun 2008 16:08:52 EDT French drug maker Sanofi-Aventis planned $2.56 billion takeover bid of Czech generics drug maker Zentiva makes sense as it could expand Sanofi's presence in Eastern Europe and give it a footing in the generics market, analysts say. http://www.ibtimes.com/articles/20080618/last-call-zentiva-bid-seens-as-move-into-generics.htm Wed, 18 Jun 2008 15:57:42 EDT Shares of Pfizer Inc. rose Wednesday after the drugmaker settled a five-year patent dispute with India's Ranbaxy Laboratories Ltd., negotiating a deal to keep a generic version of blockbuster cholesterol drug Lipitor off U.S. shelves for longer than many analysts predicted. http://www.ibtimes.com/articles/20080618/pfizer-ranbaxy-settle-lipitor-patent-dispute.htm Wed, 18 Jun 2008 15:11:24 EDT French pharmaceuticals maker Sanofi-Aventis SA said Wednesday it's planning a takeover bid for Zentiva that values the Czech generic drugs maker at $2.56 billion. http://www.ibtimes.com/articles/20080618/sanofi-aventis-bids-for-generics-maker.htm Wed, 18 Jun 2008 14:32:36 EDT Drug developer Mylan Inc. said Monday the Food and Drug Administration granted tentative approval for the generic version of Sanofi Aventis' hypertension drug Avalide. http://www.ibtimes.com/articles/20080616/mylan-gets-final-fda-ok-for-generic-antidepressant.htm Mon, 16 Jun 2008 15:16:41 EDT Danish drug maker Novo Nordisk A/S said Monday patients treated with its diabetes drug liraglutide showed significant weight loss after a year compared with those on a competing drug. http://www.ibtimes.com/articles/20080616/novo-nordisk-says-diabetes-drug-boosts-weight-loss.htm Mon, 16 Jun 2008 11:23:28 EDT A Lehman Brothers analyst said Regeneron Pharmaceuticals Inc.'s cancer drug aflibercept compares more favorably with Genentech Inc.'s Avastin than investors realize. http://www.ibtimes.com/articles/20080606/analyst-says-regeneron-oversold-on-drug-failure.htm Fri, 06 Jun 2008 17:11:44 EDT Pharmaceutical giants Merck & Co., Bristol-Myers Squibb Co. and Novartis AG will be among the companies hoping to catch the attention of physicians at the American Diabetes Association's annual meeting this weekend. http://www.ibtimes.com/articles/20080605/diabetes-treatments-take-stage-at-ada-meeting.htm Thu, 05 Jun 2008 12:57:25 EDT